KIORA PHARMACEUTICALS, INC. Capital Units, Authorized
KIORA PHARMACEUTICALS, INC. (KPRX) had Capital Units, Authorized of 50.00 million shares as of 2019-05-13, per its 10-K filed 2022-04-15.
Discontinued › Notes › Equity
us-gaap:CapitalUnitsAuthorized · last filed 2022-04-15
- 2019-05-13: Capital Units, Authorized 50.00M shares.
- 2019-05-03: Capital Units, Authorized 50.00M shares.
- 2018-09-30: Capital Units, Authorized 100.00M shares.
- 2018-06-30: Capital Units, Authorized 100.00M shares.
| Period end | Capital Units, Authorized |
|---|---|
| 2019-05-13 | 50.00M shares 10-K · filed 2022-04-15 |
| 2019-05-03 | 50.00M shares 10-Q · filed 2019-05-08 |
| 2018-09-30 | 100.00M shares 10-Q · filed 2018-11-13 |
| 2018-06-30 | 100.00M shares 10-Q · filed 2018-08-03 |
| 2018-01-02 | 100.00M shares 10-Q · filed 2018-11-13 |
| 2017-12-31 | 100.00M shares 10-Q · filed 2018-11-13 |
| 2016-05-06 | 100.00M shares 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |